Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9338 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8931 |
High Similarity |
NPD7054 |
Approved |
0.8931 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8875 |
High Similarity |
NPD7472 |
Approved |
0.8875 |
High Similarity |
NPD7074 |
Phase 3 |
0.882 |
High Similarity |
NPD6797 |
Phase 2 |
0.8765 |
High Similarity |
NPD7251 |
Discontinued |
0.875 |
High Similarity |
NPD3818 |
Discontinued |
0.8712 |
High Similarity |
NPD7808 |
Phase 3 |
0.8693 |
High Similarity |
NPD4380 |
Phase 2 |
0.8667 |
High Similarity |
NPD6799 |
Approved |
0.8645 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8599 |
High Similarity |
NPD7075 |
Discontinued |
0.8581 |
High Similarity |
NPD1549 |
Phase 2 |
0.8581 |
High Similarity |
NPD6801 |
Discontinued |
0.8537 |
High Similarity |
NPD6559 |
Discontinued |
0.8514 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8514 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8446 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8408 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8395 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8395 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8377 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8366 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8354 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8291 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8247 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8133 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8108 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8105 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8065 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8037 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7973 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7879 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7862 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7847 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7844 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7824 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7806 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7791 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7717 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7706 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD920 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD3749 |
Approved |
0.758 |
Intermediate Similarity |
NPD1243 |
Approved |
0.758 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7562 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7548 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7547 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7453 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7453 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7453 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7447 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD919 |
Approved |
0.7436 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7418 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7399 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7368 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7366 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7366 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7366 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7366 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7358 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7355 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7355 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7355 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7353 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD37 |
Approved |
0.7342 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD7228 |
Approved |
0.734 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7302 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7302 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD1613 |
Approved |
0.729 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7248 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7244 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7239 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7235 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7232 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7213 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7213 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7211 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7189 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD943 |
Approved |
0.7175 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7175 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD6100 |
Approved |
0.717 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.712 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7098 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7075 |
Intermediate Similarity |
NPD9493 |
Approved |
0.707 |
Intermediate Similarity |
NPD3142 |
Approved |
0.707 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7053 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7053 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD411 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD2403 |
Approved |
0.702 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7011 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7011 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7
|
Intermediate Similarity |
NPD4308 |
Phase 3 |